Business Context and Reporting Period
Company: GlaxoSmithKline plc
Filing Type: Form 6-K (Report of Foreign Issuer)
Date: May 09, 2012
Reporting Period: May 2012
This filing reports on the outcome of the Annual General Meeting (AGM) held on May 3, 2012. It serves as a notification to the SEC regarding corporate governance resolutions passed at the meeting.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report regarding shareholder resolutions and does not contain financial performance data.
Material Changes
No material financial changes are reported in this filing. The document confirms that all proposed resolutions at the AGM were duly passed. Copies of resolutions concerning non-ordinary business have been filed with the UK Listing Authority National Storage Mechanism.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly an administrative notice regarding the AGM outcomes.
Key Facts for Investor Verification
- All proposed resolutions at the May 3, 2012 AGM were passed.
- Resolutions regarding non-ordinary business are available for inspection via the UK Listing Authority National Storage Mechanism (www.Hemscott.com/nsm.do).
- This filing does not contain financial results; investors should refer to the company's Form 20-F or interim financial reports for performance data.